Document Detail


Treating patients with peripheral arterial disease and claudication.
MedLine Citation:
PMID:  12629492     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The vascular nurse plays an important role in the treatment of patients with peripheral arterial disease (PAD), a prevalent atherosclerotic occlusive disease that affects approximately 8 to 12 million people in the United States. Approximately 4 to 5 million individuals with PAD experience claudication, the exercise-induced ischemic pain in the lower extremities that is relieved upon rest. Both PAD and claudication are associated with increased morbidity and mortality, limitations in functional capacity, and a decreased quality of life. Despite its prevalence, PAD is often undiagnosed and, therefore, increases the risk for cardiovascular ischemic events, disease progression, functional disability, amputation, and death. Risk factors for PAD and claudication are similar to those for other atherosclerotic diseases, including age, cigarette smoking, diabetes mellitus, hypertension, dyslipidemia, and hyperhomocysteinemia. Effective treatment to normalize these risk factors can reduce disease progression and the incidence of cardiovascular ischemic events. Claudication symptoms can be improved most effectively through exercise training, which may be used in conjunction with medications specifically indicated to improve these symptoms. Vascular nurses, practicing in a multitude of inpatient and outpatient settings, can assist patients with risk-factor modifications and behavioral changes to help them stop smoking, maintain glycemic control, normalize high blood pressure and lipid levels, and ensure initiation of lifelong antiplatelet therapy and participation in exercise rehabilitation programs, thus, promoting positive outcomes for patients with claudication.
Authors:
Diane Treat-Jacobson; M Eileen Walsh
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing     Volume:  21     ISSN:  1062-0303     ISO Abbreviation:  J Vasc Nurs     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-03-11     Completed Date:  2003-04-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9014475     Medline TA:  J Vasc Nurs     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5-14; quiz 15-6     Citation Subset:  N    
Affiliation:
University of Minnesota School of Nursing, 6-101 Weaver-Densford Hall, 308 Harvard Street SE, Minneapolis, MN 55455, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Algorithms
Exercise
Humans
Intermittent Claudication / diagnosis,  epidemiology,  nursing*,  therapy
Nursing Assessment
Patient Education as Topic
Peripheral Vascular Diseases / diagnosis,  epidemiology,  nursing*,  therapy
Phosphodiesterase Inhibitors / therapeutic use
Risk Factors
United States / epidemiology
Chemical
Reg. No./Substance:
0/Phosphodiesterase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diurnal regulation of arylalkylamine N-acetyltransferase activity in chicken retinal cells in vitro:...
Next Document:  Perceived and objective risk in children of patients with peripheral arterial disease.